ECA
SNY icon

Elevated Capital Advisors’s Sanofi SNY Stock Holding History

Elevated Capital Advisors’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$811 Hold
19
– – ﹤0.01% 761
2026
Q1 		$915 Hold
19
– – ﹤0.01% 745
2025
Q4 		$921 Buy
+19
New +$942 ﹤0.01% 718

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Elevated Capital Advisors's SNY Position: Q2 2026 in Review

Elevated Capital Advisors held its Sanofi (SNY) position steady in Q2 2026 at 19 shares worth $811. The position accounts for ﹤0.01% of the portfolio, ranked #761.

Elevated Capital Advisors first reported a position in SNY in Q4 2025 and has held it in 3 quarters since. The position peaked at $921 in Q4 2025. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Elevated Capital Advisors held 19 shares of Sanofi worth $811 as of Q2 2026.
  • Elevated Capital Advisors left its Sanofi share count unchanged in Q2 2026.
  • Sanofi made up ﹤0.01% of Elevated Capital Advisors's portfolio in Q2 2026, its #761 holding.
  • Elevated Capital Advisors first reported a position in Sanofi in Q4 2025 and has held it in 3 quarters since.
  • Elevated Capital Advisors's Sanofi position peaked at $921 in Q4 2025.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Elevated Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.